ABBOTT LABORATORIES A/S: Financial statements 2017
CVR: 31528615
Source: annual report 2017, Danish Business Authority
01/01/2017 – 31/12/2017
ABBOTT LABORATORIES A/S (CVR 31528615) has filed annual accounts for 2017. In 2017, the company reported revenue of DKK 147,369,875 and a net result of DKK 5,706,415 compared with DKK 3,313,889 the year before. That is an increase of 10% compared with the year before. The profit margin was 3.9%. Equity in the 2017 report amounted to DKK 58,869,046. The solvency ratio was 71.2%. The company had 31 employees in the financial year.
- Revenue
- DKK 147,369,875
- Gross Profit
- DKK 34,396,662
- Profit/Loss
- DKK 5,706,415
- Equity
- DKK 58,869,046
- Total Assets
- DKK 82,678,655
- Employees
- 31
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | 147.4 mio. | 34.4 mio. | 5.7 mio. | 58.9 mio. | 31 |
| 2016 | 134 mio. | 38.8 mio. | 3.3 mio. | 53.2 mio. | - |
| 2015 | 140.7 mio. | 43.9 mio. | 10.5 mio. | 49.8 mio. | - |
| 2014 | 149.8 mio. | 51.3 mio. | 15.1 mio. | 39.4 mio. | - |
| 2013 | 173.2 mio. | 39.9 mio. | 3.2 mio. | 24.3 mio. | 41 |
Official annual report
Keep an eye on ABBOTT LABORATORIES A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
ABBOTT LABORATORIES A/S has published its annual report for 2016. Revenue came to DKK 133,977,634, and the net result was DKK 3,313,889.
About ABBOTT LABORATORIES A/S
ABBOTT LABORATORIES A/S is a Danish company of the type Aktieselskab based in København S, founded in 1971. The company is registered under the industry Engroshandel med læge- og hospitalsartikler. The management consists of Karl Andreas Almroth. The board consists of Bradley Jay Slater (chair), Fredrik Björn Anders Björnulfson and Karl Andreas Almroth. The company is owned by ABBOTT MEDICAL OVERSEAS CYPRUS LIMITED. The company has 48 employees (2026). In 2025, the company reported revenue of DKK 412,831,732 and a net result of DKK 63,142,932 compared with DKK 8,276,415 the year before. Equity in the 2025 report amounted to DKK 74,374,860.